Presentations
8. Yazici Y, Erkan D, Lockshin MD. Etanercept
in the treatment of severe, resistant psoriatic arthritis: Continued
efficacy and changing patterns of use after 2 years. Annals of
the Rheumatic Diseases 2002;61(S1):306 (Presented at 2002 EULAR
meeting)
9. Yazici Y, Erkan D, Harrison MJ, Paget SA. Treatment of rheumatoid
arthritis flares: Do rheumatologists agree on a standard of care?
Annals of the Rheumatic Diseases 2002;61(S1):337 (Presented at
2002 EULAR meeting)
10. Yazici Y, Erkan D, Leff L, Kulman I, Schwartzman S, Harrison
MJ. Infliximab in the treatment of rheumatoid arthritis: 18 months’ experience
of referral patterns, response to treatment, and adverse events
in a “real world” practice setting. Annals of the Rheumatic
Diseases 2002;61(S1):380 (Presented at 2002 EULAR meeting)
11. Yazici Y, Erkan D, Kulman I, Schwartzman S, Harrison MJ. Rates
of increased disease activity/flare and infection in rheumatoid
arthritis patients before and during one year of treatment with
infliximab. Annals of the Rheumatic Diseases 2002;61(S1):387 (Presented
at 2002 EULAR meeting)
12. Erkan D, Yazici Y, Lockshin MD. Catastrophic Antiphospholipid
Syndrome (CAPS) or Antiphospholipid Syndrome (APS) with a Catastrophic
Event? Lupus 2002; 11: 554 (Presented at 2002 10th International
Congress on Antiphospholipid Antibodies)
13. Erkan D, Yazici Y, Harrison MJ, Peterson M, Sammaritano L,
Lockshin MD. APLASA Study: Primary Thrombosis Prevention in Asymptomatic
Antiphospholipid Antibody (APL) Patients with Low-dose Aspirin
(ASA). (Presented at 2002 10th International Congress on Antiphospholipid
Antibodies)
14. Sokka T, Yazici Y, Pincus T. Rheumatoid arthritis remains
an erosive disease in many patients - 49% of patients with RA onset
since 1998 with 2 or more years of disease have erosions. Arthritis
Rheum 46; 9: S527, 2002 (Presented at the 2002 ACR meeting)
15. Yazici Y, Erkan D, Paget S. Common wisdom and rheumatoid arthritis
treatment practice patterns among United States rheumatologists.
Annals of the Rheumatic Diseases 2003; 62 (S1):351 (Presented at
2003 EULAR meeting)
Previous page | Next
page
|